SCHEMBL29930747

SCHEMBL29930747

CC(=O)Nc1ccc(-c2n[nH]c3ncc(Br)cc23)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 6/20 0.67
DYRK1A Q13627 5/20 0.67
TTK P33981 1/20 0.52
MAPK8 P45983 1/20 0.52
PDE5A O76074 1/20 0.49
PDE1A P54750 1/20 0.49
PDE1B Q01064 1/20 0.49
PDE3B Q13370 1/20 0.49
PDE1C Q14123 1/20 0.49
PDE3A Q14432 1/20 0.49
IDO1 P14902 2/20 0.47
CLK1 P49759 3/20 0.47
CDK5 Q00535 1/20 0.47
CDK5R1 Q15078 1/20 0.47
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
DYRK2 Q92630 1/20 0.45
PTGS2 P35354 2/20 0.44
MEN1 O00255 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930537 0.86 DYRK1A (0.69) DYRK1BDYRK1ATTKMAPK8PDE5A
SCHEMBL29930317 0.82 DYRK1B (0.68) DYRK1BDYRK1ATTKMAPK8CLK1
SCHEMBL29930540 0.80 DYRK1B (0.62) DYRK1BDYRK1AMAPK8CDK5ALDH1A1
SCHEMBL29930667 0.80 DYRK1B (0.70) DYRK1BDYRK1ATTKMAPK8CLK1
SCHEMBL29930770 0.79 DYRK1B (0.58) DYRK1BDYRK1AMAPK8IDO1CLK1
SCHEMBL38651912 0.79 NCOA1 (0.53) DYRK1BDYRK1AHTTSMN1; SMN2MEN1
SCHEMBL5061384 0.76 DYRK1A (0.57) DYRK1BDYRK1ATTKMAPK8PDE1A
SCHEMBL38652158 0.76 AURKA (0.48) DYRK1BDYRK1AMAPK8CDK5HTT
SCHEMBL28562998 0.76 DYRK1B (0.61) DYRK1BDYRK1APDE1APDE1BPDE3B
SCHEMBL4344646 0.75 PDE5A (0.50) DYRK1BDYRK1ATTKMAPK8PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed